DOSSIER · 13F-HR · Q1 2026

PURA VIDA INVESTMENTS, LLC

$15M in tracked AUM across 17 positions as of Q1 2026.

PV
CIK 0001590144 · last filed Mar 31, 2026
Total AUM
$15M
as of Q1 2026
Holdings
17
positions
Whale Score
61
61
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Portfolio Overview

PURA VIDA INVESTMENTS, LLC presents a highly concentrated, high-risk portfolio characteristic of a specialized investment strategy, likely focused on emerging growth or micro-cap opportunities. As of the reporting period ending September 30, 2025, the firm managed total assets of approximately $12.29 million across a mere five holdings. This represents a significant contraction in portfolio value, decreasing by 26.1% from the $16.63 million reported in the previous quarte...

Key Holdings

The portfolio is dominated by Beta Bionics Inc., which constitutes the largest single position at $5.59 million, representing 45.47% of the total portfolio. The manager aggressively increased this stake during the quarter, adding approximately $659,555 (an increase of 11,150%), signaling a strong conviction in the company's prospects despite the overall portfolio shrinkage.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q1 2026. Methodology

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
IMDX
INSIGHT MOLECULAR DIA INC
$3M947K20.9%
02
BBNX
BETA BIONICS INC
$3M281K18.9%
03
G31249108
ESTABLISHMENT LABS HLDGS INC
$3M45K17.2%
04
CAI
CARIS LIFE SCIENCES INC
$2M90K10.8%
05
NSPR
INSPIREMD INC
$734K451K4.9%
06
NTRA
NATERA INC
$500K3K3.4%
07
NVDA
NVIDIA CORPORATION
$436K3K2.9%
08
JPM
JPMORGAN CHASE & CO
$397K1K2.7%
09
MSFT
MICROSOFT CORP
$366K9902.5%
10
MGX
METAGENOMI THERAPEUTICS INC
$354K264K2.4%

Filing history

2026Q1Mar 31
$15M 44.4%
17 positionsView →
2025Q4Dec 31
$27M 117.7%
19 positionsView →
2025Q3Sep 30
$12M 26.1%
5 positionsView →
2025Q2Jun 30
$17M 32.5%
9 positionsLocked
2025Q1Mar 31
$13M 60.3%
6 positionsLocked
2024Q4Dec 31
$32M 79.4%
19 positionsLocked
2024Q3Sep 30
$153M 2.9%
42 positionsLocked
2024Q2Jun 30
$158M 73.4%
49 positionsLocked
2024Q1Mar 31
$593M 9.5%
51 positionsLocked
2023Q4Dec 31
$656M 24.0%
54 positionsLocked
2023Q3Sep 30
$529M 30.0%
83 positionsLocked
2023Q2Jun 30
$755M 23.6%
86 positionsLocked
Showing 12 of 45